Abstract
Regenerative medicine, poised to transform 21st century healthcare, has aspired to enrich care options by bringing cures to patients in need. Science-driven responsible and regulated translation of innovative technology has enabled the launch of previously unimaginable care pathways adopted prudently for select serious diseases and disabilities. The collective resolve to advance the design, manufacture and validity of affordable regenerative solutions aims to democratize such health benefits for all. The objective of this Review is to outline the framework and prerequisites that underpin clinical readiness of regenerative care. Integrated research and development, specialized workforce education and accessible evidence-based practice implementation are at the core of realizing an equitable regenerative medicine vision.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 309-322 |
| Number of pages | 14 |
| Journal | Regenerative Medicine |
| Volume | 16 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2021 |
Keywords
- chronic disease
- healthcare delivery
- innovation
- manufacturing
- model of care
- patient
- population
- practice
- regeneration
- regulation
- supply chain
- workforce
ASJC Scopus subject areas
- Biomedical Engineering
- Embryology